Investigation of the prevalence and clinical implications of ERBB2 exon 16 skipping mutations in Chinese pan-cancer patients

BACKGROUND: Although rare, ERBB2 exon 16 skipping mutations (ERBB2ΔEx16) have been implicated in resistance to anti-HER2 and anti-EGFR targeted agents. Our study investigated the prevalence and clinical significance of ERBB2ΔEx16 in Chinese pan-cancer patients. METHODS: We retrospectively screened 4...

Descripción completa

Detalles Bibliográficos
Autores principales: Shang, Yanhong, Mo, Jianming, Huo, Ran, Li, Xiaofang, Fang, Guotao, Wei, Zichun, Gu, Guomin, Zhu, Xiaodan, Zhang, Chan, Liu, Chunling, Yan, Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859631/
https://www.ncbi.nlm.nih.gov/pubmed/36686783
http://dx.doi.org/10.3389/fonc.2022.1064598

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859631/
https://www.ncbi.nlm.nih.gov/pubmed/36686783
http://dx.doi.org/10.3389/fonc.2022.1064598

Ejemplares similares